Page History

• We asked FidoCure if they had data on glioma, osterosarcoma, bladder cancer, mucosal and acral melanoma, and mast cell tumor.

  • Gerry Post replied “We do have data on osteosarcoma, mast cell tumors and some acral melanomas. As for gliomas and urothelial carcinomas, biopsies are much less common so we have less data.” Although he does not specify, I would think they would have lots of data on mucosal oral melanoma too.
  • If we want to pursue this further, I think Gerry would like a more specific request that he will then take to his board.

• DCG are interested in helping end users identify related cases between canine and pediatric oncology
  • Building consensus data standards between human and canine data elements
  • Mapping existing data elements in the ICDC to NCIT codes to facilitate the findability of canine data related to human data through platforms such as the Cancer Data Aggregator.   

Recently Released

ICDC Studies in Active Submission

• COTC021
  • Approved by SAC on 6/30/23
  • "Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
  • Dr. Amy LeBlanc
  • Status: Working with data submitters to provide AWS creds

• Should we repurpose the Best Practices Subcommittee to form the new Data Standardization Team?
• Should we create an outline of the goals and some next steps for aligning canine data properties and values to a controlled vocabulary?
• Which controlled vocabularies should we consider (NCIT, SnoMed, etc.)2022 BPSC Review ArticleThe manuscript entitled "Leading the Pack: Best Practices in Comparative Canine Cancer Genomics to Inform Human Oncology" has been published by the journal of Veterinary and Comparative Oncology. 

• December meeting: 12/15/23
• Ralph will send out the minutes for approval